AxoGen (NASDAQ: AXGN) reported Q4 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $59.9 million versus the consensus estimate of $58.25 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.